Nov 03 2023 This Week in Cardiology

Tricuspid regurgitation remedy, two extra left atrial appendage trials, and reflections on being too tender on medical science are the matters John Mandrola, MD, discusses on this week’s podcast.

This podcast is meant for healthcare professionals solely.

To learn a partial transcript or to remark, go to:

https://www.medscape.com/twic

I. Tricuspid Regurgitation

Trilogy TAVR Protected, Efficient in Aortic Regurgitation

https://www.medscape.com/viewarticle/997782

The TRILUMINATE Transcatheter Tricuspid Restore Trial: Optimistic however No Profit?

https://www.medscape.com/viewarticle/989105

Transcatheter Tricuspid Valve Restore Efficient, Protected for Regurgitation: TRILUMINATE

https://www.medscape.com/s/viewarticle/989103

– TRILUMINATE NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2300525

II. LAA Occlusion

Completely different Strengths for LAA Closure Gadgets?

https://www.medscape.com/viewarticle/962893

– Swiss Apero – Authentic paper https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057859

– Swiss Apero – One-year https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.067599

Peri-device Leaks After Watchman https://pubmed.ncbi.nlm.nih.gov/35902169/

TAVR With Left Atrial Appendage Occlusion Non-inferior to TAVR Plus Medical Remedy https://www.medscape.com/viewarticle/997725

– WATCH TAVR Trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.067312

You might also like:

Medscape editor-in-chief Eric Topol, MD, and grasp storyteller and clinician Abraham Verghese, MD, on Medication and the Machine

https://www.medscape.com/features/public/machine

The Bob Harrington Present with Stanford College Chair of Medication, Robert A. Harrington, MD.

https://www.medscape.com/author/bob-harrington

Questions or suggestions, please contact information@medscape.web

source